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demonstrated a lower bias in Bland-Altman analysis. Three of these 8 equations
based on a combination of creatinine and cystatin C (Schwartz et al. New equa-
tions to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629–37;
Schwartz et al. Improved equations estimating GFR in children with chronic kidney
disease using an immunonephelometric determination of cystatin C. Kidney Int
2012;82:445–53; Chehade et al. New combined serum creatinine and cystatin C
quadratic formula for GFR assessment in children. Clin J Am Soc Nephrol
2014;9:54–63) had the highest accuracy with approximately 60% of P15 and 80%
of P30. In 10 patients with a single kidney, 7 with kidney transplant, and 11 additional
children with short stature, values of the 3 equations had low bias and no significant
difference when compared with mGFR. In conclusion, the 3 equations that used
cystatin C, creatinine, and growth parameters performed in a superior manner
over univariate equations based on either creatinine or cystatin C and also had
good applicability in specific pediatric patients with single kidneys, those with a
kidney transplant, and short stature. Thus, we suggest that eGFR calculations in pe-
diatric clinical practice use only a multivariate equation. (Translational Research
2015;165:437–445)Abbreviations: BUN¼ blood urea nitrogen; eGFR¼ estimated glomerular filtration rate; mGFR¼
measured glomerular filtration rate; Scr ¼ serum creatinine; Scys ¼ serum cystatin Ceases, Department of Pediatrics,
hwestern University, Chicago, Ill;
partment of Pediatrics, Ann and
pital of Chicago, Chicago, Ill;
liated Hospital of Anhui Medical
China; Department of Pathology
and Robert H Lurie Children’s
l; Department of Pathology and
hool of Medicine, Northwestern
Submitted for publication July 3, 2014; revision submitted October 6,
2014; accepted for publication October 8, 2014.
Reprint requests: Craig B. Langman, Kidney Diseases, Ann and
Robert H. Lurie Children’s Hospital of Chicago, 225 E Chicago
Avenue, #37 Chicago, IL 60611; e-mail: c-langman@northwestern.
edu.
1931-5244
 2015 Elsevier Inc.
http://dx.doi.org/10.1016/j.trsl.2014.10.004
437
Open access under CC BY-NC-ND license.
AT A GLANCE COMMENTARY
Deng F, et al.
Background
There are many estimating glomerular filtration
rate (GFR) equations used in clinical practice.
The bedside CKiD formula, based on creatinine
only, is the most widely used formula in children.
However, recent studies mainly in adults demon-
strated that a combination of creatinine and cysta-
tin C has superior performance. Few studies have
evaluated estimating GFR equations in pediatric
patients.
Translational Significance
This study translated the field of laboratory medi-
cine for determining kidney function in children
into an improved standard of clinical practice, by
calculating the accuracy of multiple estimating
equations through careful analysis of correlations’
accuracy. When applied in 2 special populations,
we found 3 equations to remain robust when
compared with measured GFR.
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The glomerular filtration rate (GFR) is considered the
best overall index of kidney function in health and dis-
ease. Thus, accurate measured GFR (mGFR) plays an
important role in the clinical management of various
diseases, both intrinsic to the kidney and with other dis-
eases in which altered kidney function may influence
the use of therapeutic agents, for example. More than
80% of clinical laboratories now report an estimating
GFR (eGFR) when serum creatinine (Scr) is
measured.1 However, in recent years there are many
studies that have shown that eGFR equations using
additional markers of filtration, such as cystatin C,
are superior to conventional equations based on Scr
alone.2,3 These equations were tested mainly in adult
patients with chronic kidney disease (CKD), whereas
only a few studies have evaluated performance of
eGFR equations in pediatric CKD outside a research
setting.
The most popular equation currently used in children
is the 2009 Schwartz formula, which is based on Scr.4
Despite standardization of Scr assays, eGFR remains
relatively imprecise owing to variation in non-GFR de-
terminants of Scr.5 This equation does not differentiate
between gender, despite the known gender difference in
linear height and Scr concentrations, beginning in earlyadolescence. Thus, such anthropometric disparities
result in a considerable variation in muscle mass and
may be a dominant factor in eGFR differences.6 Some
studies in children have demonstrated that the inclusion
of serum cystatin C (Scys) in the estimating equation in-
creases the correlation with the mGFR than Scr alone.7,8
We compared 14 published eGFR equations against a
gold standard mathematical model for mGFR from
iohexol blood clearance9 to guide clinicians in optimal
eGFR determinations in a diverse group of children
with possible kidney dysfunction. We hypothesized
that the complex equation using gender, height, Scr,
and Scys may be highly predictive of mGFR.METHODS
Studydesignanddata. This studywas conducted at the
Ann andRobert H. Lurie Children’sHospital of Chicago,
Illinois (Lurie Children’s), from November 2012 to
January 2014. We used a single cross-sectional data set
from 81 consecutive outpatients in which iohexol-based
mGFR was calculated, based on the model used by
Schwartz et al from the Chronic Kidney Disease in
Children (CKiD) study,9 and for which we are a
participating center. At the time of the patient’s mGFR
study, additional data collected included Scr, Scys,
blood urea nitrogen, visit date, anthropometrics, and
demographics. We calculated height-for-age Z-score
according to the United States Centers for Disease
Control standards of recumbent length Z-scores, birth
to 24 months, and stature Z-scores, 2–20 years in
centimeters, by gender and age.10 Fourteen eGFR
equations were included and their respective values for
81 patients were compared against the mGFRs. This
retrospective study was approved by the Lurie
Children’s Hospital of Chicago Institutional Review
Board.
Laboratory analyses. We measured iohexol in serum
by a validated liquid chromatography tandem mass
spectroscopy method from 4 serial blood samples
collected at 10, 30, 120, and 300 minutes postiohexol
injectionwith the clearance calculated using the concen-
tration of iohexol as a function of time in 2 curves (fast
and slow plasma disappearance).9 Scr was measured
using an isotope-dilution mass spectrometry (IDMS)-
traceable enzymatic method on the Roche Cobas 6000,
following the Food and Drug Administration cleared
procedure for Roche or Hitachi Cobas C systems.
Blood urea nitrogen and cystatin C were analyzed in
serum on the Roche Cobas 6000, following the Food
and Drug Administration cleared procedures for
Roche or Hitachi Cobas C systems. The cystatin C
method on the Roche Cobas 6000 uses an automated
particle-enhanced immunoturbidimetric assay (PETIA).
Table I. Published estimated glomerular filtration rate equations in children
Equation name Equation
Scr based
Schwartz et al4 (ScrEq2009) 41.3Ht/Scr
Schwartz et al11 (ScrEq2012) 42.3(Ht/Scr)0.79
Gao et al12 68(Ht/Scr) 2 8(Ht/Scr)2 1 0.48 3 age 2 21.53 in males or 25.68 in females
Pottel et al13 107.3/(Scr/Q), Q 5 0.0270 3 age 1 0.2329
Hoste et al6 107.3/(Scr/Q), Q 5 3.94 2 13.4 L 1 17.6 L2 2 9.84 L3 1 2.04 L4
Scys based
B€okenkamp et al14 (162/Scys) 2 30
Grubb et al15 84.69Scys21.68 3 1.384 for age ,14 years
Filler and Lepage16 91.62(1/Scys)1.123
Schwartz et al4 (ScysEq2009) 41.9(1.8/Scys)0.777
Schwartz et al11 (ScysEq2012) 70.69Scys20.931
Scr and Scys based
Bouvet et al17 63.2(1.2/Scys)0.56 (1.09/Scr)0.35 (weight/45)0.3 (age/14)0.4
Schwartz et al.4 (ScrcysEq09) 39.1 (Ht/Scr)0.516(1.8/Scys)0.294(30/BUN)0.1691.099male(Ht/1.4)0.188
Schwartz et al11 (ScrcysEq12) 39.8 (Ht/Scr)0.456(1.8/Scys)0.418(30/BUN)0.0791.076male(Ht/1.4)0.179
Chehade et al18 42(Ht/Scr) 2 4(Ht/Scr)2 2 14.5Scys 1 0.69age 1 18.25 for female or 21.88 for male
Abbreviations: BUN, blood urea nitrogen (in mg/dL); Ht or L, height (in m); Scr, serum creatinine (in mg/dL); Scys, serum cystatin C (in mg/L).
Age is in years; weight is in kilograms.
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tions were selected to calculate eGFR (Table I). These
include 5 equations based on Scr alone, 5 based on
Scys alone, and 4 based on combinations of both. The
method of testing Scys was particle-enhanced
nephelometric immunoassay (PENIA) in Filler et al,16
Bouvet et al,17 Chehade et al,18 and Schwartz et al4,11
equations. The others used the PETIA method. The
method of testing Scr was Jaffe method in Gao et al,12
Bouvet et al,17 and Chehade et al18 equations. The
others used the enzymatic assay.
Statistical analyses. Continuous data were described
as the mean 6 standard deviation, median, and inter-
quartile range (IQR), and categorical variables were ex-
pressed as cases or percentages. Differences between
eGFR and mGFR were analyzed by the nonparametric
Wilcoxon test, because the data were not normally
distributed. Correlations between eGFR and mGFR
were established based on the Spearman correlation.
Bland-Altman analysis was used to compare eGFR
with mGFR using the average of the overall
mean 6 standard deviation and the precision was
represented as the width between the 95% limits of
agreement, wherein the smaller the limits of
agreement, the greater the precision. Regression
analysis and scatterplot analysis were used to compare
the agreement between eGFR and mGFR. Three
parameters used to assess the performance of eGFR
equations relative to mGFR were as follows:
 Bias (median difference between mGFR and eGFR)
and absolute bias (median difference in
jmGFR 2 eGFRj; precision (IQR: P75-P25); and
 accuracy [percentage of estimates that differed
within 15% of mGFR (P15) and 30% of mGFR
(P30)].
We selected P, 0.05 a priori to be statistically signif-
icant. Statistical analyses were completed using Statis-
tic Package for Social Science (SPSS, Inc, Chicago,
Illinois) and Medcalc (Medcalc Software, Mariekerke,
Belgium).
RESULTS
Demographicandclinicalcharacteristics. Characteristics
of interest for our study population of 81 children and ad-
olescents are shown in Table II. The minimum and
maximum ages of the participants were 0.70 and
20 years, respectively. There were 10 patients with
single kidney and 7 with a kidney transplant. The
primary diseases that resulted in a kidney transplant
were nephropathic cystinosis (4 cases), kidney dysplasia
(2 cases), and autosomal recessive polycystic kidney
disease (1 case). Five patients with Wilms tumor, 1 with
mesoblastic nephroma, and 1 with Langer Giedion
syndrome had single native kidneys after a unilateral
nephrectomy performed for clinical care.
Analysis of the differences between the eGFR andmGFR
values. The values of mGFR and the 14 corresponding
eGFR values are shown in Table III. The mean mGFR
for the 81 subjects was 77.9 6 38.8 mL/min/1.73 m2.
The median and IQR (P25, P75) were 77.8, 52.0, and
96.0 mL/min/1.73 m2, respectively. The numbers of
patients with mGFR $90, 60–89, 30–59, and
,30 mL/min/1.73 m2 were 25, 31, 17, and 8,
Table II. Characteristics of study participants
Variable Value
Measured glomerular filtration
rate test, n
81
Age, y
Mean 6 standard deviation 12.60 6 5.14
Median (P25, P75) 14.29 (8.96, 16.88)
Gender, n (%)
Female 37 (45.7)
Male 44 (54.3)
Ethnicity/race, n (%)
White 47 (58.0)
Hispanic 22 (27.2)
Black 10 (12.3)
Asian 2 (2.5)
Weight (kg), median (P25, P75) 46.30 (29.05, 60.40)
Height (cm)
Median (P25, P75) 152.30 (124.70, 167.60)
Z-score 20.77 6 1.97
Single kidney, n (%)
Native kidney 3 (3.7)
After nephrectomy 7 (8.6)
2 Kidneys, n (%) 64 (79.0)
Kidney transplantation, n (%) 7 (8.6)
Primary kidney disease, n (%)
Congenital anomalies of the
kidney and urinary tract
16 (19.7)
Glomerular disease 6 (7.4)
Tubulointerstitial disease 5 (6.2)
Solid organ transplantation
other than kidney
17 (21.0)
Metabolic disease 23 (28.4)
Other 14 (17.3)
Abbreviations: FSGS, Focal Segmental Glomerular Sclerosis;
p-ANCA, perinuclear anti-neutrophil cytoplasmic antibody;
STEC-HUS, shiga toxin escherichia coli hemolytic uremic syndrome.
Glomerulopathies include 6 patients with microscopic polyangiitis,
congenital nephrotic syndrome, thin basement membrane, FSGS,
Kawasaki disease, and p-ANCA positive microscopic polyangiitis,
respectively. Tubulointerstitial disease includes 5 patients with renal
tubular acidosis, type I, Fanconi syndrome, interstitial nephritis, Bart-
ter syndrome, and acute tubular necrosis, respectively. Solid organ
transplantation other than kidney includes patients with a trans-
plant of the liver (13), heart (1), lung (2), and bone marrow (1).
Metabolic disease includes cystinosis (5), nephrolithiasis or hyper-
calciuria (12), and 6 patients with Hashimoto’s thyroiditis, Lennox-
Gastaut syndrome, tuberous sclerosis, Mainzer-Saldino syndrome,
Langer Giedion syndrome, methylmalonic academia, respec-
tively. ‘‘Other’’ are 5 patients with Wilms tumor, 3 with renovascular
disease, 4 with mesoblastic nephroma, STEC-HUS and diabetes
mellitus, autosomal recessivepolycystic kidney disease, and neuro-
fibromatosis, respectively, and 2 with unknown etiology of chronic
kidney disease.
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correlated (P , 0.001) with the mGFR value.
However, 3 equations based on Scr alone, 1 based on
Scys, and all 4 based on combinations of both
demonstrated no significant difference from the
mGFR values (P . 0.05). These same 8 equations
also had lower bias compared with the others in the
Bland-Altman analysis.Consistency analysis of the eGFR and mGFR
values. Table IV lists the performance of the selected
8 equations determined by calculating accuracy, bias,
and precision. All had low bias, but 3 multivariate
equations based on a combination of Scr and Scys,
Schwartz et al4,11 and Chehade et al18 had the highest
accuracy with approximately 60% of P15 and 80% of
P30.
Fig 1 shows the agreement between eGFR and mGFR
for these 3 multivariate equations. There was good
agreement across the GFR range from low to high, espe-
cially for equations of Schwartz et al.4,11
Analysis of the differences between the multivariate
equation and mGFR in patients with single kidney, kidney
transplant, or short stature. On the basis of the results
mentioned previously, the 3 multivariate equations had
the best performance among all eGFR equations. We
analyzed their applicability in 10 patients with a single
kidney, 7 with kidney transplant, and 11 short stature pa-
tients with height Z-score #22.5 (Table V). From the
Wilcoxon test, there was no significant difference
between eGFR and mGFR in patients with single
kidney, kidney transplant, and short stature
(P $ 0.05). The values of the 3 equations also showed
acceptable bias and precision in the Bland-Altman
analysis.DISCUSSION
Accurate assessment of GFR is essential for interpret-
ing the symptoms, signs, and laboratory abnormalities
that may indicate kidney disease, for monitoring side ef-
fects of therapeutic drug use, and for detecting and man-
aging CKD and assessing its prognosis, among others.
The gold standard for measuring GFR was inulin clear-
ance for many years and was performed by loading and
continuously infusing inulin and collecting timed urine
samples from an indwelling bladder catheter, a proce-
dure very cumbersome and difficult to perform in chil-
dren.19 Iohexol has been used as a satisfactory marker
of GFR in adults and children, based on its ready avail-
ability, exclusive elimination by the kidneys without
further metabolism, and good agreement with inulin
and 51Cr-EDTA clearances. Indeed, iohexol has been
heralded as the new gold standard measure of GFR
and especially in children.9,20
In the present study, 8 of the 14 eGFR equations eval-
uated demonstrated better performance than the others
compared with mGFR. These 8 were a mix of equations
based on Scr only (3/5), Scys only (1/5), and a combina-
tion of both Scr and Scys (4/4). Further analysis demon-
strated that only 3 specific multivariate equations had
better performance than the univariate ones. These 3
equations all included Scr, Scys, gender, and a statural
growth parameter. When used in unique patient
Table III. Overall limits of agreement between eGFR and mGFR
Equation name Mean 6 SD
Wilcoxon test Correlation analysis Bland-Altman analysis
Z P r P Bias 95% LOA
mGFR 77.9 6 38.8 — — — — — —
Schwartz et al4 (ScrEq09) 83.4 6 48.5 21.476 0.14 0.77 ,0.001 25.5 6 26.0 256.5; 45.5
Schwartz et al11 (ScrEq12) 71.2 6 30.7 22.229 0.03 0.77 ,0.001 5.7 6 20.0 233.5; 44.9
Gao et al12 76.4 6 36.8 21.490 0.14 0.73 ,0.001 1.5 6 50.0 296.5; 99.5
Pottel et al13 85.1 6 44.5 21.923 0.054 0.72 ,0.001 27.2 6 26.4 258.9; 44.5
Hoste et al6 84.9 6 46.2 22.281 0.02 0.78 ,0.001 27.0 6 24.1 254.2; 40.2
B€okenkamp et al14 126.5 6 64.0 27.573 0.00 0.81 ,0.001 248.7 6 40.4 2127.9; 30.5
Grubb et al15 111.8 6 81.3 25.412 0.00 0.80 ,0.001 233.9 6 54.6 2140.9; 73.1
Filler and Lepage16 94.1 6 42.6 25.605 0.00 0.84 ,0.001 216.3 6 24.3 263.9; 31.3
Schwartz et al4 (ScysEq09) 65.9 6 21.1 23.962 0.00 0.84 ,0.001 12.0 6 24.6 236.2; 60.2
Schwartz et al11 (ScysEq12) 71.2 6 27.0 21.937 0.053 0.84 ,0.001 6.6 6 22.5 237.5; 50.7
Bouvet et al17 73.9 6 31.1 20.506 0.61 0.73 ,0.001 3.9 6 28.3 251.6; 59.4
Schwartz et al4 (ScrcysEq09) 77.9 6 32.3 20.445 0.66 0.87 ,0.001 20.0 6 16.5 232.3; 32.3
Schwartz et al11 (ScrcysEq12) 76.2 6 30.8 20.186 0.85 0.88 ,0.001 1.7 6 16.6 230.8; 34.2
Chehade et al18 74.4 6 28.1 20.308 0.76 0.79 ,0.001 3.4 6 31.2 257.8; 64.6
Abbreviations: eGFR, estimatedglomerular filtration rate; 95% LOA, 95% limits of agreement;mGFR, measured glomerular filtration rate; r, Spear-
man’s correlation coefficient between eGFR and mGFR; SD, standard deviation; Z, value of the Wilcoxon test between eGFR and mGFR.
The unit of GFR is mL/min/1.73 m2. The italicized rows are equations for which there is no significant difference between eGFR andmGFR in the
Wilcoxon test.
Table IV. Performance of the 8 equations in the overall sample
Equation name
Bias Precision
Absolute bias
Accuracy (%)
Median IQR (P25, P75) P15 P30
Schwartz et al4 (ScrEq09) 23.1 27.1 (216.6, 10.5) 14.0 39.5 65.4
Gao et al12 22.9 25.4 (216.7, 8.7) 11.5 51.9 71.6
Pottel et al13 23.1 27.2 (218.5, 8.7) 13.9 44.4 64.2
Schwartz et al11 (ScysEq12) 1.9 19.6 (25.0, 14.6) 8.6 53.1 79.0
Bouvet et al17 20.2 30.1 (214.0, 16.1) 15.2 34.6 64.2
Schwartz et al4 (ScrcysEq09) 22.5 18.4 (29.8, 8.6) 9.3 58.0 79.0
Schwartz et al11 (ScrcysEq12) 22.3 18.6 (28.8, 9.8) 9.2 61.7 82.7
Chehade et al18 0.7 19.9 (210.1, 9.8) 9.9 59.3 77.8
Abbreviations: eGFR, estimated glomerular filtration rate; IQR, interquartile range;mGFR, measured glomerular filtration rate; SD, standard de-
viation.
Bias was the median difference between eGFR and mGFR (mGFR 2 eGFR); absolute bias was j(mGFR 2 eGFR)j; accuracy was calculated as
the percentage of estimates of eGFR that differed from themGFRwithin 15% (P15) andwithin 30% (P30). The italicized rows are the equationswith
the highest accuracy.
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plant, and short stature), the 3 equations demonstrated
high agreement with mGFR.
There are only a few studies that have compared the
applicability of eGFR equations based on different
included variables in children. The performance
of Scr-based equations was studied in several arti-
cles.6,12,13 The bedside CKiD formula (Schwartz
et al4) is the most widely used formula for eGFR in chil-
dren. However it was derived from data obtained in chil-
dren with CKD mGFR between 15 and 75 mL/min/
1.73 m2. Several recent studies validated new Scr-
based formulas for children, which all outperformed
the bedside CKiD formula compared withmGFR.6,12,13 Sharma et al21 studied several Scys-
based equations and found the accuracy of various
Scys equations varied with the actual mGFR. In a study
focused on children with a solitary functioning kidney,
the authors used 6 eGFR equations based on Scr,
Scys, and a combination of both variables, and found
the combined formula, Schwartz et al,11 had superior
precision.22 For clinical practice, we need to identify
the most accurate eGFR equation that can be applied
to a diverse pediatric patient population. In adults, there
are several large studies capable of validating the accu-
racy of eGFR equations. One recent example, the
Chronic Kidney Disease Epidemiology Collaboration,
developed an equation based on Scr in 2009 and 2 others
Table V. Agreements between multivariate equations and mGFR in special patients
Special patient Mean 6 SD
Wilcoxon test Bland-Altman analysis
Z P Bias 95% LOA
Single kidney (n 5 10)
mGFR 66.5 6 19.2
Schwartz et al4 (ScrcysEq09) 77.3 6 22.0 21.988 0.05 210.8 6 14.5 239.2; 17.6
Schwartz et al11 (ScrcysEq12) 75.0 6 20.5 21.682 0.09 28.5 6 13.6 235.2; 52.2
Chehade et al18 77.5 6 21.2 21.988 0.05 211.0 6 15.3 241.0; 19.0
Kidney transplant (n 5 7)
mGFR 63.0 6 18.6
Schwartz et al4 (ScrcysEq09) 58.2 6 18.1 20.676 0.50 4.8 6 12.5 219.7; 29.3
Schwartz et al11 (ScrcysEq12) 57.5 6 17.5 21.014 0.31 5.4 6 12.1 218.3; 29.1
Chehade et al18 57.9 6 24.3 20.845 0.40 5.0 6 14.0 222.4; 32.4
Z-score #22.5 (n 5 11)
mGFR 59.7 6 28.5
Schwartz et al4 (ScrcysEq09) 61.4 6 20.8 20.445 0.66 21.7 6 14.9 230.9; 27.5
Schwartz et al11 (ScrcysEq12) 59.8 6 19.6 20.445 0.66 20.1 6 14.7 228.9; 28.7
Chehade et al18 64.7 6 29.8 20.978 0.33 24.9 6 19.0 242.1; 32.3
Abbreviations: eGFR, estimated glomerular filtration rate; 95% LOA, 95% limits of agreement; mGFR, measured glomerular filtration rate; SD,
standard deviation; Z, value of the Wilcoxon test between eGFR and mGFR.
The unit of GFR is mL/min/1.73 m2.
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cystatin C). They tested the 3 equations in very diverse
populations with CKD and normal kidney function and
found the combined creatinine-cystatin C equation per-
formed better than equations based on either of both
markers alone when compared with mGFR.2 The com-
bined equation is commonly used in adult hospitals as
the method for eGFR in adults, replacing the popular
Modification of Diet in Renal Disease eGFR.3,23
Similarly to others in adults and children, we found
that all 3 combined (Scr with Scys) equations
outperformed equations that used the Scr or Scys alone.
Cystatin C is freely filtered and catabolized in the
proximal tubules, without being secreted. Unlike Scr,
it does not depend on gender or muscle mass and does
not change with age between 1 and 50 years old.24
Scys increases earlier than Scr as GFR decreases, so it
may be a valuable marker in detecting early renal
dysfunction.25,26 In an early meta-analysis, Scys has
also been reported to be superior to Scr for GFR estima-
tion, particularly in patients with near-normal kidney
function.27 In addition to its use in estimating GFR, cys-
tatin C has also been associated with subsequent adverse
clinical events. In prior studies in the general population
and in the elderly, cystatin C has been shown to be a bet-
ter predictor of mortality and adverse cardiovascular
events than Scr alone.28-30 Peralta et al31 studied cysta-
tin C level in 11,909 participants and found its level may
have a role in identifying individuals with CKD who
have the highest risk for complications. The addition
of cystatin C may improve mortality risk prediction
by stages of kidney function relative to Scr.32 In ourstudy, all 3 combined equations with Scys exhibited su-
perior agreement and performance, but each of those
equations also included patient height and gender. How-
ever, including the height and gender does not explain
totally the better performance of eGFR equations,
because several other Scr-based equations used those
variables as well. It is well known that a gender differ-
ence in the correlation of growth (height) and blood
Scr concentration exists beginning in adolescence.
This large variation in body shape and linear height de-
termines extreme variations in muscle mass and may be
a dominant factor when developing eGFR formulas for
children, teens, and young adults.6
Higher cystatin C concentrations have been found in
the first year of life previously. B€okenkamp et al33 stud-
ied Scys level in 258 children without kidney disease,
aged 1 day to 18 years, and found the cystatin C concen-
tration was highest on the first days of life (range
1.646 2.59 mg/L) with a rapid decrease during the first
4months. Beyond the first year, the cystatinC concentra-
tion was constant. In a more recent study, Scys level was
found to be a superior biomarker to Scr in the assessment
of GFR in premature infants.34 It is likely that the higher
levels of cystatinC in the first year of life probably reflect
the low GFR of neonates and infants. In our study, we
only had 1 child under 1 year (0.7 years). There was a
good agreement between mGFR and eGFR based on
multivariate Schwartz equations.
It should be noted that creatinine and cystatin Cmeth-
odologies differ among the various equations and sys-
tematic differences in measurement could contribute
to the accuracy of the equations, given the methods
A B
C
Fig 1. Scatterplot regression to analyze and compare eGFR with mGFR. A, Schwartz et al4 (ScrcysEq09) eGFR
equation explains 82.5% of the variability of mGFR. B, Schwartz et al11 (ScrcysEq12) eGFR equation explains
83.1% of the variability of mGFR. C, Chehade et al18 eGFR equation explains 36.6% of the variability of
mGFR. a95% CI for the slope; b95% CI for the intercept; all P, 0.001. CI, confidence interval; eGFR, estimated
glomerular filtration rate; mGFR, measured glomerular filtration rate.
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both creatinine and cystatin C to GFR is exponential,
the effect of analytical error (bias and precision) will
be greater at lower or ‘‘normal’’ creatinine values (cor-
responding to high GFR) and the same difference will
have minimal impact at highly abnormal creatinine
values, which correspond to lowGFR. Creatinine assays
relying on both the Jaffe and enzymatic methods are
now standardized to a material characterized by a gold
standard method, IDMS-traceable method. Many of
the equations evaluated herein used an enzymatic
IDMS-traceable creatinine method, which is what we
use at our institution. The Gao et al12 Scr-only equation
is based on a Jaffe IDMS-traceable method, and we
found this equation, using our creatinine values, to
have high agreement with mGFR.
The methodological differences noted between cysta-
tin C assays lead to similar limitations that were histor-
ically experienced with creatinine and various eGFR
equations. Efforts are now underway to calibrate
different cystatin C methods to a single traceable refer-
ence material. The first report of a virtually assay-
independent simple cystatin C-based eGFR equationbased on calibration of different methods to an interna-
tional reference material was recently published.35 In
the present study, our laboratory used a PETIA method
on the Roche Cobas 6000 e501. Most of the equations
evaluated reportedly used a PENIA method, most
commonly that on the Siemens Bulk Nanocrystallized
Ingot Iron platform. Hansson et al36 showed in a com-
parison of 180 patient samples that Passing-Bablok
regression analyses yielded a slope of 0.904 and inter-
cept of 0.21 with regression coefficient of 0.9343 for
cystatin C measured by Roche Cobas e501 cystatin C
PETIA and Siemens Bulk Nanocrystallized Ingot Iron
PENIA. Despite the limitations because of analytical
differences among methods, we have shown that the
combination of creatinine and cystatin C improves ac-
curacy to mGFR.
The primary strength of this study is that it compares
performance of 14 published eGFR equations in pediat-
ric patients evaluated against an accurate and precise
mGFRmethod in the routine clinical setting. The effects
of different variables in the eGFR formulas were
compared using a rigorous analytic plan to test the for-
mulas against mGFR. Different analytic methods
Translational Research
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equation. No previous study has specifically assessed
the comparison of these comprehensive equations in
this age group. The limitations of this study include a
relatively small sample of subjects, and the analysis
was not based on CKD stage, owing to a relatively small
number expected in some groups. However, in data
shown from the scatterplot regression analyses, a stron-
ger correlation can be seen with worsening CKD stage
than in CKD stage 1, especially for the 2 Schwartz
multivariate equations. Alternatively, the high overall
correlation suggests that it would not have been
different by differing stage of CKD with greater patient
numbers within the lower bounds of mGFR.
CONCLUSIONS
Themultivariate eGFR equations performed in a supe-
rior fashion than the univariate equations. The 3 eGFR
formulas based on a combination of Scr, Scys, gender,
and a growth parameter (Schwartz et al4,11 and
Chehade et al18) demonstrated exceptional accuracy
among all formulas and had good applicability in special
patients including those with a single kidney, kidney
transplant, and short stature. Adding height and Scys
to eGFR formula seems to be important in improving ac-
curacy of the estimating equation. Our data suggest that
for best accuracy to mGFR, all eGFR calculations in pe-
diatric clinical practice use only multivariate equations,
particularly 1 of the 3 mentioned previously. As this is a
small study, our recommendations need to be confirmed
in a larger sample size.ACKNOWLEDGMENTS
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